Skip to Content

Frequently Searched

Supported by

Up Close with Linvoseltamab

Last Updated: May 16, 2025

This section provides an overview of linvoseltamab-gcpt (LYNOZYFIC™).

Download PDF Here

Related Resources:

Patient Education Sheet

Linvoseltamab

Last Updated: 09/24/2025

Find Similar Resources:

Immunotherapy
Immunotherapy

Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)

Last Updated: 02/19/2026
 Immunotherapy

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance

Last Updated: 07/01/2025
PQI Podcast

S10 E5: Best Practices for Subcutaneous Administration of Anticancer Therapies

Last Updated: 03/24/2026
 Patient Education Sheet

Ibrutinib and Rituximab

Last Updated: 03/10/2026
 Patient Education Sheet

Acalabrutinib and BR

Last Updated: 03/10/2026
 Patient Education Sheet

Lenalidomide and Rituximab

Last Updated: 03/10/2026
Last Updated: 03/24/2026